SS-31

Clinical Trials

Elamipretide (MTP-131)

Aliases
Elamipretide, MTP-131, Bendavia
Administration
Subcutaneous injection, IV infusion (clinical)

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Injection site reactions

Mild redness, swelling, or discomfort at the site of injection.

Well-tolerated in clinical trials

Clinical trial data has not identified significant safety concerns.